Mr. Alvaro Torres reports

KHIRON LIFE SCIENCES AGREES TO $500,000 SECURED DEPOSIT

Khiron Life Sciences Corp. has agreed to a $500,000 non-interest-bearing refundable deposit from 2518542 Alberta Ltd. (251), a company controlled by Avonlea-Drewry Holdings Inc., to be secured by all of Khiron's present and after-acquired property pursuant to a general security agreement and a pledge of Khiron's shares in its subsidiaries, Pharmadrug Production GmbH and Zerenia Clinics U.K. Ltd.

The deposit is to be advanced to the company pursuant to the terms and conditions of a letter of intent between, among others, Khiron and 251, whereby Khiron has granted 251 the exclusive right to negotiate the terms and conditions for the possible sale and acquisition of Khiron's European subsidiaries. The completion of the proposed transaction is subject to, among other things, the negotiation of a definitive purchase agreement and the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange. If the proposed transaction is completed, then the full amount of the deposit will be set off against the aggregate purchase price for the assets. There can be no assurance that the proposed transaction will be completed if at all and in the event that such proposed transaction is not completed, then the company will be required to repay the deposit.

About Khiron Life Sciences Corp.

Khiron is a leading global medical cannabis company with core operations in Latin America and Europe. Leveraging wholly owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and focus on creating access to drive prescriptions and brand loyalty with patients worldwide. The company has a sales presence in Colombia, Germany, the United Kingdom, Switzerland, Peru and Brazil. The company is led by its co-founder and chief executive officer, Alvaro Torres, together with an experienced and diverse executive team and board of directors.

We seek Safe Harbor.